Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 56 of 1,261
  1. WO 2025051711

    TRAITEMENT PAR PTH D'UNE MALADIE RÉNALE CHRONIQUE

    ASCENDIS PHARMA BONE DISEASES AS [DK] · Granted Mar 13, 2025 · Expires Mar 8, 2045

    granted
  2. WO 2025052303

    ARN CIRCULAIRE ET PROCÉDÉS DE PRÉPARATION ASSOCIÉS

    BEIGENE SWITZERLAND GMBH [CH] · Granted Mar 13, 2025 · Expires Mar 8, 2045

    granted
  3. US 12246092

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  4. US 12247004

    2-amino-N-(amino-oxo-aryl-lambda6-sulfanylidene)acetamide compounds and their therapeutic use

    Oxford Drug Design Limited · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  5. US 12247063

    Cell surface modification by coating with peptide amphiphiles (PAs)

    Northwestern University · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  6. US 12246027

    Compositions of bile acids and phenylbutyrate compounds

    Amylyx Pharmaceuticals, Inc. · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  7. US 12247025

    Processes for preparation of soluble guanylate cyclase stimulators

    Cyclerion Therapeutics, Inc. · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  8. US 12247052

    CpG amphiphiles and uses thereof

    Elicio Therapeutics, Inc. · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  9. US 12247059

    Conjugates of an IL-2 moiety and a polymer

    Nektar Therapeutics · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  10. US 12246086

    Applications and imaging of shear-thinning biomaterial

    The Regents of the University of California · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  11. US 12247973

    Plasma membrane citrate transporter for use in the diagnosis and treatment of cancer

    UNIVERSITÄTSKLINIKUM REGENSBURG · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  12. US 12246096

    Self-assembled microcapsules with stimuli-responsive organic ligands

    The Regents of the University of California · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  13. US 12246057

    Transmembrane stem cell factor (tm-SCF) lipid nanocarriers and methods of use thereof

    The Board of Regents of the University of Texas System · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  14. US 12246056

    Compositions and methods for the production of cysteine

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  15. US 12246047

    Adeno-associated virus purification methods

    Takeda Pharmaceutical Company Limited · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  16. US 12246023

    Use of reboxetine to treat narcolepsy

    AXSOME THERAPEUTICS, INC. · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  17. US 12247201

    Materials and methods for treatment of autosomal dominant retinitis pigmentosa

    CRISPR THERAPEUTICS AG · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  18. US 12247213

    Treatment of mucopolysaccharidosis IVA

    REGENXBIO INC. · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  19. US 12247245

    Selectivity screening for antimicrobial compounds

    Northwestern University · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  20. US 12247978

    Compositions and methods for detection and treatment of coronavirus infection

    Arizona Board of Regents on Behalf of Northern Arizona University · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  21. US 12247021

    Substituted tetrahydrofurans as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  22. US 12247226

    Cellular reprogramming using temporal and transient plasmid vector expression system

    Fate Therapeutics, Inc. · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  23. US 12247206

    Soluble interleukin-7 receptor (SIL7R) modulating therapy to treat autoimmune diseases and cancer

    The Board of Regents of the University of Texas System · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  24. US 12246064

    Method of treating Crohn's disease by administering a triple combination therapy of anti-integrin antibody, adalimumab and methotrexate

    Takeda Pharmaceutical Company Limited · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.